MedPath

Comparing the efficacy of two antibiotic groups for gram negative sepsis in intensive care unit

Phase 1
Conditions
Health Condition 1: R99- Ill-defined and unknown cause of mortalityHealth Condition 2: I958- Other hypotensionHealth Condition 3: B998- Other infectious diseaseHealth Condition 4: J17- Pneumonia in diseases classified elsewhereHealth Condition 5: R579- Shock, unspecified
Registration Number
CTRI/2024/04/065863
Lead Sponsor
Trishita Saha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patients giving consent and age more than 18 years and culture positive for MBL.

Exclusion Criteria

The patient/relatives who refuse to give informed consent and Age less than 18 years andPatients having gram negative infections caused by CRAB/Non MBL and Pregnant females and Moribund and Brain dead patients and Patients with known allergy to given drug regime.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
primary outcome is To compare the cure rate among two groups by culture negative report. <br/ ><br>Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
The secondary objectives will be <br/ ><br>To observe the Procalcitonin (PCT) and Proadrenomedullin levels in both the groups. <br/ ><br>To compare the neutrophil to lymphocyte ratio(NLR) in both the groups.To determine the length of ICU stay in both groups.To find out the 28-day all-cause mortality in both groups <br/ ><br>Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath